Utreloxastat (INN, USAN, JAN; developmental code names EPI-857 and PTC-857) is a 15-lipoxygenase (15-LOX; ALOX15) inhibitor which is under development for the treatment of amyotrophic lateral sclerosis (ALS).
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.